David Miklos, MD, PhD, discusses the latest findings at the ASH 2017 meeting in Atlanta.
Publish Date
Ibrutinib for Graft Versus Host Disease
Please login or register first to view this content.
Want to read more?
Next post in Hematologic Cancers
